| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 05/15/1991 | EP0357730A4 Blocking, isolating and purifying calcium channels |
| 05/15/1991 | EP0286643B1 Pharmaceutically active derivatives of glutamic and aspartic acids |
| 05/15/1991 | EP0282502B1 Imidazole derivatives |
| 05/15/1991 | CA2029974A1 Modified gangliosides and the functional derivatives thereof |
| 05/15/1991 | CA2029965A1 Stabilization and maintenance of the nerve growth factor biological activity by use of natural gangliosides or derivatives thereof |
| 05/14/1991 | US5015659 Cognition activators to slow aging of the brain |
| 05/14/1991 | US5015656 Antidepressants, anxiolytic compounds, central nervous system active compounds for psychotic conditions, aminoalkylcarboxami de derivatives of thiophene |
| 05/14/1991 | US5015655 1-azabicycloalkane derivatives, their preparation process and their use as medicaments |
| 05/14/1991 | US5015654 Pharmaceutical compositions |
| 05/14/1991 | US5015646 Buspirone for treatment of anxiety |
| 05/14/1991 | US5015645 Cognition activators |
| 05/14/1991 | US5015637 Pyrido[3,4-b]pyrrolo[1,2-e][1,4,5]oxadiazepines |
| 05/14/1991 | CA1284248C Pyrrolidone derivatives |
| 05/14/1991 | CA1284152C 1'-ethoxycarbonyloxyethyl ester of valproic acid, its preparation and pharmaceutical compositions containing it |
| 05/08/1991 | WO1991006288A1 A nicotine containing stimulant unit |
| 05/08/1991 | EP0426656A2 Process for the preparation of 2-arylpropionic acids |
| 05/08/1991 | EP0426488A1 Production of modified superoxide dismutase |
| 05/08/1991 | EP0426479A1 Use of a composition for the manufacture of a medicament for curing the symptoms of overindulgence |
| 05/08/1991 | EP0426468A2 Stabile polymorphic form of (E)-N,N-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl) acrylamide and the process for its preparation |
| 05/08/1991 | EP0426416A1 Novel morpholinol compounds, their preparation and use |
| 05/08/1991 | EP0426018A2 Thiophene compounds and their pharmaceutical uses |
| 05/08/1991 | CN1051182A Polypeptides useful as blockers of calcium channels |
| 05/08/1991 | CA2029222A1 Pyridine derivatives, pharmaceutical compositions containing them and process for preparing same |
| 05/07/1991 | US5013863 Learning enhancement |
| 05/07/1991 | US5013753 Derivatives of gamma-glutamyl-L-dopa, treatment of Parkinson's disease and cardiovascular diseases |
| 05/07/1991 | US5013741 N-[substituted alkylidene]-1,2,3,4-tetrahydro-9-acridinamines useful for enhancing the cholinergic function in a mammal |
| 05/07/1991 | US5013737 2,4,8-Trisubstituted-3H,6H-1,4,5A,8A-tetraazaacenaphtylene-3,5-(4H)-diones and 2,4-8-trisubstituted-4,5-dihydro-5-thioxo-3H,6H-1,4,5A,8A-tetrazaacenaphthylen-3-ones |
| 05/07/1991 | US5013735 Method of treating therapy-resistant schizophrenia with amperozide (N-ethyl-4-(4',4'-bis(p-fluorophenyl)butyl)-1-piperazine-carboxamide |
| 05/07/1991 | US5013733 Lactam derivatives |
| 05/07/1991 | US5013558 Pharmaceutical treatments for cerebral and neuronal diseases |
| 05/07/1991 | CA2029334A1 Morpholine derivatives, their method of preparation and pharmaceutical compositions in which they are present |
| 05/07/1991 | CA2029275A1 Aromatic amine compounds, their method of preparation and pharmaceutical compositions in which they are present |
| 05/03/1991 | WO1991006529A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | CA2067569A1 Glutamic and aspartic acid derivatives with antigastrin activity and a method for their preparation |
| 05/03/1991 | CA2029216A1 Process of producing modified superoxide dismutase |
| 05/02/1991 | WO1991005776A1 3-aryl oxazolidinones and their preparation and use |
| 05/02/1991 | WO1991005775A1 Aryl-3 oxazolidinones and their preparation and use |
| 05/02/1991 | WO1991005774A1 3-aryl oxazolidinones and their preparation and use |
| 05/02/1991 | WO1991005559A1 Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction |
| 05/02/1991 | EP0425235A2 Cytotoxic agents comprising maytansinoids and their therapeutic use |
| 05/02/1991 | EP0425209A2 Naphthyloxazolidone derivatives |
| 05/02/1991 | EP0425096A1 Polypeptides useful as blockers of calcium channels |
| 05/02/1991 | EP0424670A1 ZNS-active hexapeptides with antiamnestic activity |
| 05/02/1991 | EP0424543A1 New s-adenosylmethionine derivative |
| 05/02/1991 | EP0424528A1 Phenylalkanoylamine derivatives, process for their preparation, and their uses |
| 05/02/1991 | EP0211928B1 Piperazinecarboxamides having a phenoxyalkyl or thiophenoxyalkyl side chain |
| 05/01/1991 | WO1991006573A1 Inhibitor of laminin neurite promoting activity |
| 05/01/1991 | CN1051042A Process for preparing derivatives substituted in position 15 of 20,21 dinoreburnamenine |
| 05/01/1991 | CN1051039A W-phenoxy-heterocyclic compounds |
| 05/01/1991 | CA2066658A1 Inhibitor of laminin neurite promoting activity |
| 05/01/1991 | CA2028496A1 Thiophene compounds and their pharmaceutical uses |
| 04/30/1991 | US5011952 Phospholipase A2 inhibitor |
| 04/30/1991 | US5011928 Analgesic and antiinflammatory derivatives of 1-acyl-4-arylalkylpiperazines |
| 04/30/1991 | US5011849 Monoamine oxidase inhibitors |
| 04/30/1991 | US5011841 4,7-methanoisoindole derivative |
| 04/30/1991 | US5011834 PCP receptor ligands and the use thereof |
| 04/30/1991 | US5011833 Novel derivatives of 6,11-dihydro-dibenzo(C,F)(1,2,5)-thiadiazepine 5,5-dioxide, salts thereof and appropriate processes for the preparation thereof |
| 04/30/1991 | CA1283657C 1,5-benzothiazepine derivatives, their preparation and compositions containing them |
| 04/28/1991 | CA2028645A1 Use of arylalkylamides in the treatment of neurodegenerative diseases |
| 04/26/1991 | WO1991006542A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 04/26/1991 | WO1991006536A1 Method of inhibiting the transport of l-glutamate |
| 04/26/1991 | CA2069912A1 Method of inhibiting the transport of l-glutamate |
| 04/26/1991 | CA2065305A1 Pharmaceutically active amino-substituted heteroaryl amines |
| 04/24/1991 | EP0424315A2 Tetracyclic pyrrole lactam derivatives |
| 04/24/1991 | EP0424248A2 20,21-Dinoreburnamine derivatives, substituted in position 15, process for their preparation and novel intermediates so obtained, their use as medicines and compositions containing them |
| 04/24/1991 | EP0424244A1 3-Aryl oxazolidinone derivatives, their preparation and their therapeutical use |
| 04/24/1991 | EP0424243A1 3-Aryl oxazolidinones, process for their preparation and their therapeutical use |
| 04/24/1991 | EP0424059A1 Use of sustituted imidazoles for the manufacture of an analgesic |
| 04/24/1991 | EP0424028A2 S(+)-ibuprofen-L-amino acid and S(+)-ibuprofen-D-amino acid as onset hastened enhanced analgesics |
| 04/24/1991 | EP0423943A2 Use of collagenase inhibitors in the treatment of demyelinating diseases, in particular multiple sclerosis |
| 04/24/1991 | EP0423870A1 Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives |
| 04/24/1991 | EP0423802A1 Phenoxy-heterocyclic compounds |
| 04/24/1991 | EP0423695A2 Aerosol composition for topical medicament |
| 04/24/1991 | EP0423524A2 Propiophenone derivatives and their preparation and pharmaceutical use |
| 04/24/1991 | EP0423236A1 Peptides with extraordinary opioid receptor selectivity |
| 04/24/1991 | CN1050875A Aroyl-urres |
| 04/23/1991 | US5010108 Treatment of gastrointestinal disorders |
| 04/23/1991 | US5010096 Administering benzodioxino pyrrole compounds; adrenergic blocking agents |
| 04/23/1991 | US5010090 Anxiolytic, antiepilepic agents; muscular disorders |
| 04/23/1991 | US5010074 Treating CNS disorders; dopamine antagonist; bioavailability |
| 04/23/1991 | US5010072 Lactamimides as calcium antagonists |
| 04/23/1991 | US5010056 Pharmaceutical composition for intranasal administration, comprising GH-releasing hormone, a cholinergic agonist and optionally a bile salt |
| 04/23/1991 | US5009895 Sustained release with high and low viscosity HPMC |
| 04/21/1991 | CA2027838A1 Dibenzodioxazecine and dibenzodioxaazacycloundecine derivatives |
| 04/20/1991 | CA2027952A1 Topical medicinal pressurized aerosol compositions and method of preparation, method of use and article of manufacture thereof |
| 04/20/1991 | CA2027840A1 Tetracyclic pyrrole lactam derivatives |
| 04/18/1991 | WO1991005552A1 Method and compositions for inhibition of disorders associated with oxidative damage |
| 04/18/1991 | WO1991005038A1 Blood-brain barrier model |
| 04/18/1991 | WO1991004735A1 Compositions and methods for weight reduction |
| 04/18/1991 | WO1991004316A3 Ciliary neurotrophic factor |
| 04/18/1991 | CA2027724A1 15-substituted 20,21-dinoreburnamenine derivatives, process for preparing the same and new intermediates thus produced, use thereof as drugs and compositions containing them |
| 04/18/1991 | CA2027715A1 3-aryloxazolidinone derivatives process for their preparation and their use in therapy |
| 04/18/1991 | CA2027702A1 Pyridone products, preparation process, new intermediates obtained, application as drugs and pharmaceutical compositions containing them |
| 04/18/1991 | CA2027624A1 S (+)-ibuprofen-l-amino acid and (+)-ibuprofen-d-amino acid as onset-hastened enhanced analgesics |
| 04/18/1991 | CA2027243A1 Intraoral formulated trifluorobenzodiazepines and the use thereof |
| 04/17/1991 | EP0423032A2 Process for the preparation of isoxazolyl and isothiazolyl imidazobenzodiazepines, new derivatives thus obtained, their use as medicaments and compositions containing them |
| 04/17/1991 | EP0422889A2 Phenethanolamine compounds |
| 04/17/1991 | EP0422878A1 (2-Imidazolin-2-ylamino) tetrahydroquinoxalines and methods for using same |
| 04/17/1991 | EP0422846A2 Aroyl-ureas |
| 04/17/1991 | EP0422666A2 6-Substituted-1,2,3,4-tetrahydroisoquinolines |